• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕酮在多药耐药细胞和妊娠子宫的子宫内膜中与P-糖蛋白相互作用。

Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.

作者信息

Yang C P, DePinho S G, Greenberger L M, Arceci R J, Horwitz S B

机构信息

Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461.

出版信息

J Biol Chem. 1989 Jan 15;264(2):782-8.

PMID:2562956
Abstract

P-Glycoprotein (P-GP) plays a pivotal role in maintaining the multidrug-resistant (MDR) phenotype. This membrane glycoprotein is overproduced in MDR cells and the endometrium of the mouse gravid uterus (Arceci, R.J., Croop, J.M., Horwitz, S.B., and Housman, D. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 4350-4354). This latter observation and an interest in endogenous substrates for P-GP led to a study of the interaction of steroids with P-GP found in the endometrium of the mouse gravid uterus and in MDR cells derived from the murine macrophage-like cell J774.2. [3H]Azidopine labeling of P-GP from these two sources was inhibited by various steroids, particularly progesterone. Progesterone also markedly inhibited [3H]vinblastine binding to membrane vesicles prepared from MDR cells, enhanced vinblastine accumulation in MDR cells, and increased the sensitivity of MDR cells to vinblastine. In addition, we have demonstrated that the hydrophobicity of a steroid is important in determining its effect on inhibition of drug binding to P-GP. It is concluded that progesterone, a relatively nontoxic endogenous steroid, interacts with P-GP and is capable of reversing drug resistance in MDR cells.

摘要

P-糖蛋白(P-GP)在维持多药耐药(MDR)表型中起关键作用。这种膜糖蛋白在MDR细胞和小鼠妊娠子宫的子宫内膜中过量产生(Arceci, R.J., Croop, J.M., Horwitz, S.B., and Housman, D. (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 4350 - 4354)。后一观察结果以及对P-GP内源性底物的兴趣,促使人们对类固醇与在小鼠妊娠子宫子宫内膜和源自鼠巨噬细胞样细胞J774.2的MDR细胞中发现的P-GP之间的相互作用进行研究。来自这两种来源的P-GP的[3H]叠氮平标记受到各种类固醇的抑制,尤其是孕酮。孕酮还显著抑制[3H]长春碱与从MDR细胞制备的膜囊泡的结合,增强长春碱在MDR细胞中的积累,并增加MDR细胞对长春碱的敏感性。此外,我们已经证明类固醇的疏水性在决定其对抑制药物与P-GP结合的作用方面很重要。得出的结论是,孕酮是一种相对无毒的内源性类固醇,它与P-GP相互作用并能够逆转MDR细胞中的耐药性。

相似文献

1
Progesterone interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus.孕酮在多药耐药细胞和妊娠子宫的子宫内膜中与P-糖蛋白相互作用。
J Biol Chem. 1989 Jan 15;264(2):782-8.
2
Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.叠氮平在多药耐药细胞中与长春碱和环孢素A非竞争性地相互作用,从而与P-糖蛋白结合。
J Biol Chem. 1991 Sep 5;266(25):16796-800.
3
Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.多药转运蛋白P-糖蛋白的调节剂存在于人体血浆中。
Biochem Biophys Res Commun. 1990 Jan 15;166(1):74-80. doi: 10.1016/0006-291x(90)91913-d.
4
N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.N-(对叠氮基-3-[¹²⁵I]碘苯乙基)螺哌隆与人神经母细胞瘤细胞中的P-糖蛋白及另一种多药结合蛋白——螺哌嗜素的特定区域结合。
Biochemistry. 1994 Jan 11;33(1):256-65. doi: 10.1021/bi00167a034.
5
BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.BIBW22 BS是一种强效的多药耐药逆转剂,它直接与P-糖蛋白结合并在耐药细胞中蓄积。
Mol Pharmacol. 1996 Sep;50(3):482-92.
6
Megestrol acetate reverses multidrug resistance and interacts with P-glycoprotein.醋酸甲地孕酮可逆转多药耐药性并与P-糖蛋白相互作用。
Cancer Chemother Pharmacol. 1992;29(6):445-9. doi: 10.1007/BF00684845.
7
Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.吲哚生物碱对多药耐药性的影响以及长春碱光亲和类似物对P-糖蛋白的标记
Biochem Biophys Res Commun. 1988 Jun 30;153(3):959-66. doi: 10.1016/s0006-291x(88)81321-4.
8
Characterization of the azidopine and vinblastine binding site of P-glycoprotein.P-糖蛋白的叠氮平与长春碱结合位点的表征
J Biol Chem. 1992 Oct 15;267(29):21020-6.
9
Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.多药耐药相关P-糖蛋白ATP酶的竞争性和非竞争性抑制——多部位模型的进一步实验证据
Eur J Biochem. 1997 Mar 1;244(2):664-73. doi: 10.1111/j.1432-1033.1997.00664.x.
10
Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.逆转多药耐药性的药物是分离囊泡对[3H]长春碱转运的抑制剂。
Biochim Biophys Acta. 1991 Jan 9;1061(1):106-10. doi: 10.1016/0005-2736(91)90274-c.

引用本文的文献

1
Polyoxypregnane Aryl Esters Prepared from (Thunb.) Makino and Their Role in Reversing Multidrug Resistance in HepG2/Dox Cells.从(Makino的文献中)制备的聚氧孕烷芳基酯及其在逆转HepG2/Dox细胞多药耐药性中的作用 。 备注:你提供的原文中“(Thunb.) Makino”部分信息不完整,推测可能是某植物学名相关的内容,以上翻译是基于现有信息尽量完整呈现的结果。
Pharmaceuticals (Basel). 2025 Aug 12;18(8):1187. doi: 10.3390/ph18081187.
2
Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1).非营养性甜味剂乙酰磺胺酸钾和三氯蔗糖是人体 P-糖蛋白/多药耐药蛋白 1(PGP/MDR1)的竞争性抑制剂。
Nutrients. 2023 Feb 23;15(5):1118. doi: 10.3390/nu15051118.
3
Utilization of Photoaffinity Labeling to Investigate Binding of Microtubule Stabilizing Agents to P-Glycoprotein and β-Tubulin.
利用光亲和标记研究微管稳定剂与 P-糖蛋白和β-微管蛋白的结合。
J Nat Prod. 2022 Mar 25;85(3):720-728. doi: 10.1021/acs.jnatprod.2c00106. Epub 2022 Mar 3.
4
Progestins as Anticancer Drugs and Chemosensitizers, New Targets and Applications.孕激素作为抗癌药物和化学增敏剂:新靶点与新应用
Pharmaceutics. 2021 Oct 4;13(10):1616. doi: 10.3390/pharmaceutics13101616.
5
In vitro modulation of multidrug resistance by pregnane steroids and in vivo inhibition of tumour development by 7α-OBz-11α(R)-OTHP-5β-pregnanedione in K562/R7 and H295R cell xenografts.孕烷类固醇对多药耐药的体外调节及 7α-OBz-11α(R)-OTHP-5β-孕烷二酮对 K562/R7 和 H295R 细胞异种移植瘤发展的体内抑制作用。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):684-691. doi: 10.1080/14756366.2019.1575825.
6
A2A adenosine receptor modulates drug efflux transporter P-glycoprotein at the blood-brain barrier.A2A 腺苷受体调节血脑屏障处的药物外排转运体 P-糖蛋白。
J Clin Invest. 2016 May 2;126(5):1717-33. doi: 10.1172/JCI76207. Epub 2016 Apr 4.
7
Colorectal cancer susceptibility: apparent gender-related modulation by ABCB1 gene polymorphisms.结直肠癌易感性:ABCB1基因多态性对其明显的性别相关调节作用
J Biomed Sci. 2014 Sep 4;21(1):89. doi: 10.1186/s12929-014-0089-8.
8
Polymers influencing transportability profile of drug.聚合物影响药物的可传递性特征。
Saudi Pharm J. 2013 Oct;21(4):327-35. doi: 10.1016/j.jsps.2012.10.003.
9
Hormone response in ovarian cancer: time to reconsider as a clinical target?卵巢癌中的激素反应:是否应重新考虑将其作为临床靶点?
Endocr Relat Cancer. 2012 Nov 9;19(6):R255-79. doi: 10.1530/ERC-12-0175. Print 2012 Dec.
10
Predicting binding to p-glycoprotein by flexible receptor docking.通过柔性受体对接预测对 P-糖蛋白的结合。
PLoS Comput Biol. 2011 Jun;7(6):e1002083. doi: 10.1371/journal.pcbi.1002083. Epub 2011 Jun 23.